The JOLT Effect: Selling to a Buyer Who Cannot Decide
The loss that shows no competitor and no rejection. What the JOLT research names, why the standard urgency playbook makes it worse, and the four moves that answer it.
JOLT is a framework for deals that stall after the buyer has accepted the problem. It names four moves: judge the level of indecision, offer your recommendation, limit the exploration, and take risk off the table. It treats fear of choosing badly as separate from comfort with the status quo.
Key takeaways
- Fear of not changing and fear of changing badly are different problems, and the standard urgency playbook is built for the first one only.
- Agreement combined with delay is the signature of indecision, while disagreement combined with delay is an ordinary objection that existing instruments handle.
- Offering a direct recommendation and closing open questions runs against sales training that treats neutrality and completeness as professionalism.
- Taking risk off the table changes what happens if the buyer is wrong, which a discount does not do, and a lost-reason field that separates no decision from competitive loss makes the problem countable.
Reviewed and updated August 16, 2026
A deal does everything right and then stops. The buyer agreed the problem was real, brought two colleagues into the room, asked for a security review and told you the timeline. Then the replies get slower, the next meeting moves twice, and eventually nothing. No competitor won it. Nobody said no. The JOLT Effect is a named response to that specific outcome, and it starts by insisting that the buyer's silence is a different problem from the buyer's inertia.
What the research behind it looked at
The JOLT Effect is a book by Matt Dixon and Ted McKenna, and Dixon is described on Challenger's own site as a co-author of The Challenger Sale, which is why the two frameworks keep appearing together. Challenger's own page on the research describes the origin: in the spring of 2020 the pair set out to determine why so many promising deals were ending in a loss, beginning with 2.5 million recorded sales conversations, converting the audio to text with speech recognition and applying machine learning to identify 8,300 factors that drive sales success and loss.
That page states the findings plainly enough to quote directly. Challenger's own page reports that "medium to high levels of indecision show up in 87% of all deals". The same published page states that "we can attribute 40-60% of lost deals to indecision". It also reports what happened when reps met a wavering customer by returning to the start of their pitch and hyping the cost of inaction: "in 84% of these interactions, this pattern increased the likelihood the deal would be lost". The JOLT Effect's own curriculum page makes the positioning claim directly: no other sales methodology really addresses customer indecision, which is the heart of the approach.
Those numbers belong to that research and that page, and they are the reason the framework exists rather than a reason to adopt it. The argument underneath them is what matters, and the argument is testable against your own closed-lost records this afternoon.
Two different fears, and only one of them is on the standard curriculum
Almost every sales methodology in circulation is built to defeat the status quo. Teach the buyer that their current approach is costing them something, quantify it, create tension, and the purchase becomes rational. That machinery answers the fear of not changing.
Indecision is the other fear: the fear of changing badly. A buyer who has already accepted that the problem is real can still be afraid of choosing the wrong option, of missing information that would have changed their mind, of being the person who signed for something that did not work. Nothing in the status-quo playbook touches any of that, which is why the standard response makes it worse. Pushing harder on the cost of inaction says, in effect, that a buyer who is afraid of getting it wrong should hurry up.
- Buyer does not accept the problem is worth solving
- Standard answer: teach, quantify the cost of inaction, build tension
- Works when the buyer is comfortable
- Buyer accepts the problem and cannot commit to an option
- Standard answer makes it worse by adding pressure
- Ends as no decision, recorded as lost to nobody
The tell that you are in the second case rather than the first is that the buyer keeps agreeing with you. Agreement plus delay is the signature. Disagreement plus delay is an ordinary objection, and the usual instruments handle it.
The four moves, as the framework names them
Challenger's page sets out the acronym as J for Judge the Level of Indecision, O for Offer Your Recommendation, L for Limit the Exploration and T for Take Risk Off the Table.
- Step 1Judge
Establish whether this is indecision or ordinary reluctance, before choosing a response
- Step 2Offer
Give the buyer your recommendation, in the first person, with the reasoning attached
- Step 3Limit
Stop widening the evaluation and close the questions that are still open
- Step 4Take risk off
Change the shape of the commitment so a wrong choice costs less
Judge is a diagnostic step and the reason the other three do not fire at the wrong target. The signals are behavioural rather than verbal: requests for more information that does not bear on the decision, new stakeholders arriving late without a defined role, meetings rescheduled rather than cancelled, and a buyer who asks what other customers did instead of what they should do.
Offer your recommendation is the move most sellers have been trained out of. Asked which option to take, the reflex is to present the trade-offs neutrally and let the buyer choose, which reads as professionalism and lands as abandonment. A buyer stuck between three configurations does not need a fourth summary of the differences. They need somebody who has done this many times to say which one they would pick and why, and to be specific enough that the reasoning can be checked.
Limit the exploration runs against the instinct to answer every question. More options and more information increase the chance of a stall, because each new consideration reopens a decision that was closing. The practical version is not withholding anything. It is closing questions rather than collecting them: answering what is asked, saying explicitly what does not need to be evaluated and why, and being willing to tell a buyer that a particular comparison will not change their outcome.
Take risk off the table is the one that gets misread as discounting. A discount lowers the price of a decision the buyer is still afraid of, which is why it so often fails to move anything. Removing risk changes what happens if the decision turns out wrong: a smaller first commitment, a defined checkpoint at which continuing is a fresh choice, a scope that proves the thing works before the expensive part starts, an explicit statement of what you will do if a named outcome does not appear.
What this asks of a pipeline, not just a call
A framework about indecision has consequences for how deals are recorded. If nearly half of losses end in no decision, then a pipeline whose lost reasons are only competitor names and price is describing a market it is not actually losing in. The cheap fix is a lost reason that distinguishes a buyer who chose somebody else from a buyer who chose nothing, applied to the stages a deal passes through so the two are countable separately.
The second consequence lands on forecasting. A deal held by an enthusiastic buyer with no owner and no date is the exact profile that ends in no decision, and it is also the profile that looks healthy in a weekly review. That is a qualification problem before it is a closing problem, which is why the frameworks that ask who is responsible for the outcome do more forecast work than the ones that ask how interested everyone is. It shows up early, in what the first real conversation establishes, rather than at the point where a proposal is already out.
- No: Buyer disagrees with the problem framing
- Yes: Buyer agrees, and asks for information that does not change the decision
- Yes: New stakeholder arrives late with no defined role
- Yes: Meetings get rescheduled rather than cancelled
- Yes: Buyer asks what comparable companies chose, not what they should do
- No: A named person is accountable for the outcome and a date exists
Where it sits beside the Challenger approach
The two are complementary by design, and Challenger's own page says so: it frames JOLT as the playbook for what happens after a seller has taught, tailored and taken control and the buyer still will not commit. The Challenger approach is aimed at a buyer who has not accepted the problem. JOLT is aimed at a buyer who has. Read as one sequence of ideas, the first half is about creating a reason to act and the second half is about making acting feel survivable.
That also means JOLT is not a replacement for a qualification framework or for a methodology that shapes the whole revenue motion. It is a late-deal instrument with an early-deal implication, which is that a buying group without an accountable owner will produce indecision no matter how well the seller performs.
Where we differ from standard practice
Our own work sits before any of this, in outbound, and the doctrine there is deliberately narrow. We send one message per campaign. No bumps, no thread replies, and no second message tucked under the first one on LinkedIn, because a second message under an ignored one reads as a bump whatever the campaign structure says. A prospect who does not reply has not refused anything, and the honest way to reach them again is a new campaign on a new angle, launched when something changes, rather than pressure applied to the same thread.
The connection to indecision is direct. The pressure playbook the JOLT research found to be counterproductive inside a deal is the same instinct that produces bumping in outbound, and it fails for the same reason: repetition is a demand for a decision from somebody who has not been given a reason to make one. The version of this that does work is a trigger, meaning something changed at the account that makes a fresh approach relevant, and the way we structure an outbound programme is built around that rather than around persistence. We also agree the criteria that make a meeting qualified with the client in writing before a campaign launches, and budget, timing and authority are never billing conditions. The full argument for the sending constraint, including what it costs us, is in why we stopped using follow-ups.
The short version
A campaign built on those terms is the fastest way to see what the difference looks like in practice. JOLT names the loss that does not appear in a competitive review: the buyer who agreed with everything and then chose nothing. Judge whether you are facing indecision rather than reluctance, offer a real recommendation instead of another neutral summary, close open questions rather than collecting more of them, and change the shape of the commitment so that being wrong costs less. Then check your own closed-lost records for how many deals ended with nobody winning, because that number decides whether any of this is worth your attention.
Frequently asked questions.
Frequently asked questions- What does JOLT stand for?
- Judge the level of indecision, offer your recommendation, limit the exploration, and take risk off the table. Challenger publishes that expansion on its page about the research, which came from The JOLT Effect by Matt Dixon and Ted McKenna. The four moves are meant to be used in that order.
- How is JOLT different from the Challenger approach?
- Challenger is aimed at a buyer who has not accepted that the problem is worth solving, and works by teaching, tailoring and taking control. JOLT is aimed at a buyer who has accepted it and still cannot commit. Challenger describes the two as complementary, with JOLT covering what happens afterwards.
- Why does creating urgency backfire on an indecisive buyer?
- Because urgency answers the wrong fear. A buyer worried about choosing badly hears pressure as a demand to hurry a decision they are already afraid of getting wrong. Challenger reports that when reps responded this way, the pattern increased the likelihood the deal would be lost in most of those interactions.
- How do you tell indecision from an ordinary objection?
- Watch whether the buyer agrees with you. Requests for information that does not bear on the decision, late stakeholders with no defined role, meetings rescheduled rather than cancelled, and questions about what other companies chose all point at indecision. Stated disagreement points at an objection instead.
About the author.
Ben Carden is CRO at RevenueFlow, which builds and operates outbound revenue engines for B2B companies. Previously at Gartner Enterprise. Studied at London School of Economics.
Ben Carden · CRO
Connect on LinkedIn →Explore more.
Ready to scale your outreach?
We build GTM engines that book real meetings. See the receipts.
Related articles.
CHAMP: Qualification That Starts With the Problem
CHAMP is BANT with the letters moved, and the order is the argument. What each of the four checks should produce, and which one predicts a deal ending in nothing.
The Customer-Centric Sales Process: The Edit That Actually Changes Anything
Renaming the pitch achieves nothing. Writing every step as buyer evidence changes the forecast within a quarter, and three other things nobody warns you about.
B2B Sales Methodologies: The Four Arguments Behind Sixteen Names
Sixteen named frameworks collapse into four arguments about what sellers get wrong. Which family fits where your deals die, and why adoption fails more often than choice.
Solution Selling: The Generic Term, the Licensed Method, and What Survived
One name covers a generic problem-led posture and a specific licensed methodology. The lineage, the three moves that matter, and the assumption that aged badly.
The Sales Process: Writing Steps a Buyer Has to Complete
The seven-step template names things the seller does, so a process built on it advances in quarters where nothing is bought. What to write instead, and how.
The Consultative Sales Process: What Diagnosis Costs Before It Pays
Diagnosis before prescription is easy to say and expensive to run. What the approach actually requires, and why proposal volume falls before close rate rises.